![Athena Countouriotis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Athena Countouriotis
Director/Board Member at
BIOMARIN PHARMACEUTICAL INC.
Net worth: 1 M $ as of 30/06/2026
Profile
Athena Countouriotis is on the board of Iovance Biotherapeutics, Inc., NuMedii, Inc. and Passage Bio, Inc. and President, Chief Executive Officer & Director at Turning Point Therapeutics, Inc. Dr. Countouriotis previously was Director-Oncology Global Clinical Research at Bristol Myers Squibb Co., Chief Medical Officer & Senior Vice President for Halozyme Therapeutics, Inc., Chief Medical Officer & Senior Vice President for Adverum Biotechnologies, Inc., Associate Medical Director at CTI BioPharma Corp. and Chief Medical Officer of Ambit Biosciences Corp. Dr. Countouriotis received a doctorate from Tufts University School of Medicine and an undergraduate degree from the University of California, Los Angeles.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 02/06/2026 | 21,040 ( 0.01% ) | 1 M $ | 30/06/2026 | |
PASSAGE BIO, INC. 0.03% | 19/05/2026 | 945 ( 0.03% ) | 4 612 $ | 30/06/2026 |
| 16/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Latest news about Athena Countouriotis
Athena Countouriotis active positions
| Companies | Position | Start |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Director/Board Member | 10/06/2019 |
| PASSAGE BIO, INC. | Director/Board Member | 01/02/2020 |
| BIOMARIN PHARMACEUTICAL INC. | Director/Board Member | 27/12/2023 |
Avenzo Therapeutics, Inc.
 Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Chief Executive Officer | - |
Capstan Therapeutics, Inc.
 Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops targeted in vivo RNA technologies | Chairman | 12/10/2022 |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Chairman | 12/09/2022 |
NuMedii, Inc.
 NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies | Director/Board Member | 20/06/2018 |
Leal Therapeutics, Inc.
 Leal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops neuro-metabolic therapies for CNS disorders | Director/Board Member | - |
Former positions of Athena Countouriotis
| Companies | Position | End |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Director/Board Member | 24/01/2020 |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Athena Countouriotis
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
52
1st degree connections
17
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 17 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage structure-based drug design company for discovery and development of precision medicines for cancer and other diseases | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
NuMedii, Inc.
NuMedii, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies | Commercial Services |
Adverum Biotechnologies, Inc.
 Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Commercial Services |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops targeted in vivo RNA technologies | Commercial Services |
Leal Therapeutics, Inc.
Leal Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops neuro-metabolic therapies for CNS disorders | Health Technology |
Avenzo Therapeutics, Inc.
Avenzo Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development for oncology therapies used in treating of cancer | Health Technology |
- Stock Market
- Insiders
- Athena Countouriotis
